Chief Operating Officer
Bryan Dechairo serves as the Chief Operating Officer at GeneDx. In his role Bryan oversees the company’s Product & Technology, Operations, Medical Affairs, Innovation, and Program Management teams. He is responsible for driving operational excellence as the company enters the next phase of commercial growth.
Bryan brings over 30 years of experience in exploratory and commercial diagnostic businesses, driving the development of revenue-generating clinical innovations that enhance patient outcomes. He most recently served as President and CEO of Sherlock Biosciences, where he successfully transformed the company from a research-stage start-up into a commercial operation. Bryan has also held executive leadership roles at prominent diagnostic and pharmaceutical companies, including Pfizer, Myriad Genetics, Assurex, Medco Health and others. Bryan holds a PhD in Human Genetics from the University College of London and a BA in Integrative Biology from the University of California Berkeley.
